Genoptix: After-Hours Trading
Citing two people with "knowledge of the process," the
article states Genoptix has hired
Barclays plc to handle the sale. The Carlsbad, Calif.-based company wasn't immediately available for comment.
The stock was last quoted at $21.05, up 17%, on volume of nearly 30,000, according to Nasdaq.com. Based on a regular session close at $17.98, the shares were down about 49% so far in 2010. The stock has seen a slight bounce since scraping its 52-week low of $15.50 on June 24 but it's still off 54% since hitting its high for the year of $39 on May 5. The company's market capitalization was around $316 million.
Genoptix provides diagnostic test services related to hematology and oncology. The company reported its fiscal third-quarter results on Nov. 4, posting a profit of $4.4 million, or 24 cents a share, for the three months ended Sept. 30 on revenue of $49.5 million. The EPS performance was 11% ahead of Wall Street's consensus estimate for earnings of 22 cents a share in the September period.
International Coal GroupShares of International Coal Group (ICO) lost ground in late trades after announcing a secondary offering of nearly 35 million common shares. The Scott Depot, W. Va.-based company said shareholders WL Ross & Co. and Fairfax Financial Holdings Ltd. have started their sales of 12.3 million and 22.6 million shares, respectively. International Coal, which won't receive any proceeds from the sales, said BofA Merrill Lynch is acting as the sole book-running manager. The amount of stock being offered by each party represents roughly half of their holdings in the company. The stock slipped 6.4% to $7.64 on volume of almost 30,000, according to Nasdaq.com. Year-to-date, the shares were up around 120% based on their regular session finish at $8.16. The stock hit a 52-week high of $8.58 during Friday's session. -- Written by Michael Baron in New York.
>To contact the writer of this article, click here: Michael Baron.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV